118 related articles for article (PubMed ID: 33278547)
1. Curcumin rescue p53Y220C in BxPC-3 pancreatic adenocarcinomas cell line: Evidence-based on computational, biophysical, and in vivo studies.
Malhotra L; Goyal HKV; Jhuria S; Dev K; Kumar S; Kumar M; Kaur P; Ethayathulla AS
Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129807. PubMed ID: 33278547
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of apoptosis activation by Curcumin rescued mutant p53Y220C in human pancreatic cancer.
Malhotra L; Sharma S; Hariprasad G; Dhingra R; Mishra V; Sharma RS; Kaur P; Ethayathulla AS
Biochim Biophys Acta Mol Cell Res; 2022 Dec; 1869(12):119343. PubMed ID: 36007676
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids as potential reactivators of structural mutation p53Y220C by computational and cell-based studies.
Malhotra L; Kaur P; Ethayathulla AS
J Biomol Struct Dyn; 2023 Aug; ():1-12. PubMed ID: 37643005
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and Apoptotic Effect of Dendrosomal Curcumin Nanoformulation in P53 Mutant and Wide-Type Cancer Cell Lines.
Montazeri M; Pilehvar-Soltanahmadi Y; Mohaghegh M; Panahi A; Khodi S; Zarghami N; Sadeghizadeh M
Anticancer Agents Med Chem; 2017; 17(5):662-673. PubMed ID: 27604683
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells.
Dasiram JD; Ganesan R; Kannan J; Kotteeswaran V; Sivalingam N
Biomed Pharmacother; 2017 Feb; 86():373-380. PubMed ID: 28011386
[TBL] [Abstract][Full Text] [Related]
6. Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS production and endoplasmic reticulum stress mediated apoptosis.
Cheng T; Zhang Z; Shen H; Jian Z; Li J; Chen Y; Shen Y; Dai X
J Nanobiotechnology; 2020 Sep; 18(1):126. PubMed ID: 32891174
[TBL] [Abstract][Full Text] [Related]
7. Wild type p53 function in p53
Sundar D; Yu Y; Katiyar SP; Putri JF; Dhanjal JK; Wang J; Sari AN; Kolettas E; Kaul SC; Wadhwa R
J Exp Clin Cancer Res; 2019 Feb; 38(1):103. PubMed ID: 30808373
[TBL] [Abstract][Full Text] [Related]
8. [6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells.
Park YJ; Wen J; Bang S; Park SW; Song SY
Yonsei Med J; 2006 Oct; 47(5):688-97. PubMed ID: 17066513
[TBL] [Abstract][Full Text] [Related]
9. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma.
Liontas A; Yeger H
Anticancer Res; 2004; 24(2B):987-98. PubMed ID: 15161054
[TBL] [Abstract][Full Text] [Related]
10. Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53.
Liu X; Zhang L; Thu PM; Min W; Yang P; Li J; Li P; Xu X
Sci China Life Sci; 2021 Aug; 64(8):1295-1310. PubMed ID: 33165811
[TBL] [Abstract][Full Text] [Related]
11. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
[TBL] [Abstract][Full Text] [Related]
12. New orally active DNA minor groove binding small molecule CT-1 acts against breast cancer by targeting tumor DNA damage leading to p53-dependent apoptosis.
Saini KS; Hamidullah ; Ashraf R; Mandalapu D; Das S; Siddiqui MQ; Dwivedi S; Sarkar J; Sharma VL; Konwar R
Mol Carcinog; 2017 Apr; 56(4):1266-1280. PubMed ID: 27813185
[TBL] [Abstract][Full Text] [Related]
13. Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis.
Shi Y; Sahu RP; Srivastava SK
BMC Cancer; 2008 Oct; 8():294. PubMed ID: 18847491
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
15. Curcumin induced apoptosis is mediated through oxidative stress in mutated p53 and wild type p53 colon adenocarcinoma cell lines.
Sritharan S; Sivalingam N
J Biochem Mol Toxicol; 2021 Jan; 35(1):e22616. PubMed ID: 32864863
[TBL] [Abstract][Full Text] [Related]
16. Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53.
Kabir M; Sun N; Hu X; Martin TC; Yi J; Zhong Y; Xiong Y; Kaniskan HÜ; Gu W; Parsons R; Jin J
J Am Chem Soc; 2023 Jul; 145(27):14932-14944. PubMed ID: 37365684
[TBL] [Abstract][Full Text] [Related]
17. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma.
Zanotto-Filho A; Braganhol E; Edelweiss MI; Behr GA; Zanin R; Schröder R; Simões-Pires A; Battastini AM; Moreira JC
J Nutr Biochem; 2012 Jun; 23(6):591-601. PubMed ID: 21775121
[TBL] [Abstract][Full Text] [Related]
18. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
Mahmud M; Piwoni A; Filipczak N; Janicka M; Gubernator J
PLoS One; 2016; 11(12):e0167787. PubMed ID: 27936114
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
Lu YY; Jing DD; Xu M; Wu K; Wang XP
World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
[TBL] [Abstract][Full Text] [Related]
20. A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.
Garufi A; Baldari S; Pettinari R; Gilardini Montani MS; D'Orazi V; Pistritto G; Crispini A; Giorno E; Toietta G; Marchetti F; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2020 Jun; 39(1):122. PubMed ID: 32605658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
